Studies, research and what the evidence actually says — methods and caveats included.
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
Researchers say it could help identify those most at risk of developing psychosis.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
People who consumed THC were more likely to recall words that were never shown to them.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
New research suggests that long-term, heavy cannabis use is associated with subtle changes to the brain’s frontal cortex.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological […]
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners. By October, monthly volumes […]
